临床数据结合建模与模拟表明老年人药物相互作用强度不变
该研究基于瑞士HIV队列中≥55岁老年人的临床数据及已发表数据,验证了生理药代动力学(PBPK)模型预测老年人药物相互作用(DDI)的能力,并模拟了成年期50种DDI场景。结果表明衰老不影响DDI强度,临床管理可相似。
要点
- 衰老不改变DDI强度,与药物、机制、介体或性别无关。
- PBPK模型预测值与临床观察数据总体在95%置信区间内一致。
- 无严重合并症时,老年男性和女性的DDI临床管理可 priori 相似。
核心结论
- 衰老不影响药物相互作用强度,临床管理可相似。
研究设计与样本
- 基于瑞士HIV队列≥55岁老年人临床数据及已发表数据验证PBPK模型,并模拟50种DDI场景。
主要发现
- 四个DDI场景在老年人中DDI强度不变。
- 所有临床观察数据总体在PBPK模拟的95%置信区间内被预测。
- 50种DDI场景中42种仅在20-50岁成人中验证而无老年人临床数据。
- DDI强度不受衰老影响,无论涉及药物、DDI机制、介体或性别。
- 17项已发表独立DDI研究在年轻和老年受试者中证实DDI强度不变。
临床怎么用
- 无严重合并症时,老年男性和女性的DDI临床管理可 priori 相似。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Age-related comorbidities and consequently polypharmacy are highly prevalent in the elderly, resulting in an increased risk for drug-drug interactions (DDIs). The effect of aging on DDI magnitudes is mostly uncertain, leading to missing guidance regarding the clinical DDI management in the elderly. Clinical data obtained in aging people living with HIV ≥ 55 years, who participated in the Swiss HIV Cohort Study, demonstrated unchanged DDI magnitudes with advanced aging for four studied DDI scenarios. These data plus published data for midazolam in the presence of clarithromycin and rifampicin in elderly individuals assessed the predictive potential of the used physiologically-based pharmacokinetic (PBPK) model to simulate DDIs in the elderly. All clinically observed data were generally predicted within the 95% confidence interval of the PBPK simulations. The verified model predicted subsequently the magnitude of 50 DDIs across adulthood (20-99 years) with 42 scenarios being only verified in adults aged 20-50 years in the absence of clinically observed data in the elderly. DDI magnitudes were not impacted by aging regardless of the involved drugs, DDI mechanism, mediators of DDIs, or the sex of the investigated individuals. The prediction of unchanged DDI magnitudes with advanced aging were proofed by 17 published, independent DDIs that were investigated in young and elderly subjects. In conclusion, this study demonstrated by combining clinically observed data with modeling and simulation that aging does not impact DDI magnitudes and thus, clinical management of DDIs can a priori be similar in aging men and women in the absence of severe comorbidities.
引用
- Stader F, Courlet P, Kinvig H, et al. Clinical Data Combined With Modeling and Simulation Indicate Unchanged Drug-Drug Interaction Magnitudes in the Elderly. Clin Pharmacol Ther. 2020. PMID: 32772364. doi:10.1002/cpt.2017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。